Experts tie chemotherapy to slight increase in AML risk

02/14/2013 | HealthDay News

Patients who underwent chemotherapy for non-Hodgkin lymphoma and esophageal, prostate and cervical cancers had an increased risk of developing acute myeloid leukemia, a study found. However, chemotherapy was associated with lower AML risk in ovarian cancer and myeloma, researchers said.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC